This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Case Western Reserve University. Active years: 2018-2023.
Location History:
- Cleveland, OH (US) (2019 - 2021)
- Rocky River, OH (US) (2018 - 2023)
Company Filing History:
Years Active: 2018-2023
Title: Innovations by Miguel E Quinones-Mateu
Introduction
Miguel E Quinones-Mateu is a prominent inventor based in Cleveland, OH (US). He has made significant contributions to the field of HIV research, particularly in the quantification of HIV reservoirs and co-receptor tropism. His work has led to the development of innovative methods that enhance our understanding of HIV and its behavior in infected individuals.
Latest Patents
Miguel holds 4 patents, with his latest innovations including:
1. **Method of quantifying HIV reservoirs by induced transcription based sequencing** - This method involves obtaining a blood sample from an HIV+ subject, isolating CD4+ T cells, and administering HIV transcription inducing agents. The process allows for the determination of the latent HIV reservoir level in the subject by analyzing the nucleic acid sequences of the isolated RNA.
2. **Method for detecting HIV-1 co-receptor tropism** - This method determines HIV-1 co-receptor tropism in an HIV-infected patient by preparing an HIV-1 envelope protein coding sequence and using it in a cell-to-cell fusion assay.
Career Highlights
Miguel E Quinones-Mateu is affiliated with Case Western Reserve University, where he conducts his research and develops his innovative methods. His work has been instrumental in advancing the understanding of HIV and improving treatment strategies for patients.
Collaborations
Miguel collaborates with notable researchers in the field, including Eric J Arts and Kevin V King. Their combined expertise contributes to the advancement of HIV research and the development of new methodologies.
Conclusion
Miguel E Quinones-Mateu is a key figure in HIV research, with a focus on innovative methods that enhance the understanding of the virus. His contributions through patents and collaborations continue to impact the field significantly.
